Heart medtech Anteris raises $39m to fund clinical strategy
SYDNEY: Anteris Technologies, a dual-listed heart medtech backed by L1 Capital and New ... read more
Treasury Wine dumps forecasts amid trouble in China and the US
MELBOURNE: Treasury Wine Estates has abandoned its profit guidance following weaker-than-expected sales of ... read more










